Fulvestrant plus capivasertib for metastatic breast cancer. Dekker TJA. Lancet Oncol 2020;21:e232.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dekker TJA. Fulvestrant plus capivasertib for metastatic breast cancer. Lancet Oncol 2020;21:e232.
PMID: 32359497